Navigation Links
R. Kerry Clark and Robert J. Palmisano Join Bausch & Lomb Board of Directors
Date:9/23/2009

ROCHESTER, N.Y., Sept. 23 /PRNewswire/ -- Bausch & Lomb, the global eye health company, today announced R. Kerry Clark and Robert J. Palmisano have joined its board of directors.

"We are adding two outstanding business leaders with broad and relevant experience," said Gerald M. Ostrov, chairman and chief executive officer, Bausch & Lomb. "Choices like these help us become better positioned for long-term growth. We welcome Kerry and Bob and look forward to benefiting from their unique backgrounds and expertise."

Mr. Clark retired in September 2009 as chairman and chief executive officer of Cardinal Health, Inc. (NYSE: CAH), a Fortune 20 company. Under his leadership, Cardinal Health acquired numerous medical technologies that helped the company expand its service to hospitals, pharmacies and clinicians across the United States. Before his leadership at Cardinal Health, Mr. Clark spent more than 30 years at Procter & Gamble Co., where he last served as vice chairman of the board. Mr. Clark is currently a director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor's degree from Queens University.

Mr. Palmisano is the president, chief executive officer and director of ev3 Inc. (Nasdaq: EVVV), a leading global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3, Mr. Palmisano was president and chief executive officer for IntraLase Corp., which designed and developed laser products for vision correction, until IntraLase was acquired by Advanced Medical Optics, Inc. He also served as president and chief executive officer for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon, Inc. Mr. Palmisano has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as senior vice president and president of its eyewear division. He holds a bachelor's degree from Providence College.

Mr. Clark and Mr. Palmisano join board members Joseph P. Landy, Elizabeth H. Weatherman and Sean D. Carney, all managing directors of Warburg Pincus LLC; D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe; Richard Wallman, retired chief financial officer, Honeywell International, Inc.; and Gerald M. Ostrov.

About Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
2. Kerry Extends, Improves Small Business Innovation Program
3. Kerry, Snowe Push Finance Committee on Small Business Health Care
4. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
5. National Press Club to Host NEWSMAKER Media Briefing on Improving the Cost of Healthcare with R. Kerry Clark
6. Kerry Teel Named President of Premier Anesthesia
7. Senate Passes Senator Kennedys Historic Bill to Regulate Tobacco Products; Senator Kerry Votes to Protect Americas Kids From Tobacco
8. Bob Woodruff, SGM (ret) Colin Rich and Senator John Kerry honored at IBMISPS Annual Awards
9. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
10. General Wesley K. Clark (Ret.) to Address Home Care Professionals
11. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Hamlin ... to announce that they are sponsoring a raffle. Throughout the month of February, patients ... will receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... PHILADELPHIA (PRWEB) , ... February 23, 2017 , ... ... risk and uncertainty in clinical trials, today announced that Premier Research, a leading ... management solution. , Clinical trials are becoming increasingly complex, due in part to ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and ... children with autism spectrum disorder (ASD) to see films in an environment that ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... her Smiling Patriot program today with a new Indiegogo campaign . ... care to homeless veterans in the Los Angeles area, either as a participating patient ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 LG Innotek today announced that the company ... As its sterilization performance is 1.5 times higher than the competitor,s ... rays in the range of 200 -- 280nm, allowing it to be ... destroying their DNA. LG Innotek,s product emits UV in the range ... Until ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Cardiac Prosthetic Devices Market is ... next decade to reach approximately $8.9 billion by 2025. ... the given segments on global as well as regional levels presented ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
Breaking Medicine Technology: